Pharmaceutical Technology-03-02-2012

Issue PDF
Pharmaceutical Technology

March 02, 2012

Solubility : Using Nanotechnology to Tackle Key Challenges in Bioavailability

Pharmaceutical Technology
Special Reports

March 02, 2012

The standardization of upstream and downstream bioprocessing is growing, but several kinks need to be ironed out.

Pharmaceutical Technology
Special Reports

March 02, 2012

Nanosupensions are among the ways formulation scientists seek to address the problem of solubility.

Pharmaceutical Technology
Agent-in Place

March 02, 2012

In a world where product recalls can mean the end of a company, all batches must be perfect.

Pharmaceutical Technology
Pharma Ingredients

March 02, 2012

Regulatory bodies, standard-setting organizations, and industry seek to tackle the problem of counterfeit drugs and securing the flow of pharma ingredients.

BioForum
Pharmaceutical Technology

March 02, 2012

The divide between innovation and conflict of interest in medical research is not so clear.

Special Features
Pharmaceutical Technology

March 02, 2012

Genotoxic impurities and how to identify them and control for them have been a concern for several years in the pharmaceutical manufacturing industry. Pharmaceutical Technology spoke with Bo Shen, PhD, principal scientist at Amgen and chair of the AAPS Pharmaceutical Trace Impurities Focus Group, to gain insight on key challenges.

Pharmaceutical Technology
In the Field

March 02, 2012

Brazil's generic-drug market is growing steadily.

Inside USP
Pharmaceutical Technology

March 02, 2012

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

Pharmaceutical Technology
Peer-Reviewed Research

March 02, 2012

In Part II of a three-part article, the authors examine impurities from chiral molecules, polymorphic contaminants, and genotoxic impurities.

Wirelessly controlled microchips may offer an alternative to injection-based drug delivery

Viewpoint
Pharmaceutical Technology

March 02, 2012

SOCMA's Bulk Pharmaceuticals Task Force outlines key goals and challenges for user-fee legislation.

Pharmaceutical Technology
From The Editor

March 02, 2012

Has the long-awaited guidance answered all of the industry's questions?

Pharmaceutical Technology

Social media use raises questions about applying old standards to new information technology.

Pharmaceutical Technology

FDA's treatment of whistleblowers lacks internal consistency.

Pharmaceutical Technology
In the Spotlight

March 02, 2012

New product reviews for March 2012.

Pharmaceutical Technology
Outsourcing Outlook

March 02, 2012

The evolving bio/pharmaceutical business model poses risk for CMOs.

Pharmaceutical Technology

A Q&A with Chris Meissner, president of Meissner Filtration Products, on recent industry trends.